Moneycontrol PRO
Loans
Loans
HomeAuthorR sree ram Opinion

R. Sree Ram

News Editor

Moneycontrol

TCS at $200 billion mcap milestone -- What sets it apart from others

BUSINESS

TCS at $200 billion mcap milestone -- What sets it apart from others

Organic talent development, breadth of services and superior return ratios help TCS stand out among the large IT services firms

Rising demand, low capacity additions improve outlook for thermal sector

BUSINESS

Rising demand, low capacity additions improve outlook for thermal sector

Thermal power sector utilisation levels increased to 59 percent in August on a 21 percent rise in electricity generation. But long term outlook depends on discom reforms

Moneycontrol Pro Panorama | A mixed picture on inflation signals caution

BUSINESS

Moneycontrol Pro Panorama | A mixed picture on inflation signals caution

In today’s edition of Moneycontrol Pro Panorama: Board-room coup at Zee Entertainment, Sansera Engineering IPO, Hindustan Unilever, inflation and more

Coal India’s Goldilocks situation contingent on production ramp-up, price hikes

BUSINESS

Coal India’s Goldilocks situation contingent on production ramp-up, price hikes

Rising demand and firm prices in the e-auctions will benefit Coal India. But the company has to do more to drive a sustained recovery in earnings

Adani Ports’ growth ambitions get a fillip from Exim trade recovery

BUSINESS

Adani Ports’ growth ambitions get a fillip from Exim trade recovery

Adani Ports aims to double its cargo volume by FY25, capturing as much as 40 percent of India’s Exim trade

Fertiliser and agrochemical companies face multiple headwinds in FY22

BUSINESS

Fertiliser and agrochemical companies face multiple headwinds in FY22

Crop sowing numbers show a normal picture. But the monsoon's uneven spread has hurt sales of agrochemicals while supply constraints are weighing on fertiliser volumes

Moneycontrol Pro Panorama | What can keep the recovery on course?

BUSINESS

Moneycontrol Pro Panorama | What can keep the recovery on course?

In today’s edition of Moneycontrol Pro Panorama: Taking guard on festive pitch, the bond rally, account aggregator ripple effect, Xi’s hallmarks, Coforge, Clean Science and Technology and more

Revival in engineering services spend puts L&T Tech, Tata Elxsi firmly on growth path

BUSINESS

Revival in engineering services spend puts L&T Tech, Tata Elxsi firmly on growth path

L&T Technology Services' FY25 revenue target implies an average annual growth of 19 percent between FY21-25. That's good news for Tata Elxsi, too

Crossword sale will reduce costs, but bigger battle awaits Shoppers Stop

BUSINESS

Crossword sale will reduce costs, but bigger battle awaits Shoppers Stop

Crossword lost money last fiscal and Shoppers Stop has lowered the value of its investment in the unit

NCR focus to yield good dividends for Max Healthcare

BUSINESS

NCR focus to yield good dividends for Max Healthcare

Shares of Max Healthcare gained 15 percent this week after the company said it has acquired the rights to develop and operate a 500-bed hospital at Saket, South Delhi

Moneycontrol Pro Panorama | Spurt in electricity prices: no easy solutions

BUSINESS

Moneycontrol Pro Panorama | Spurt in electricity prices: no easy solutions

In today’s edition of Moneycontrol Pro Panorama: Economic recovery tracker, June quarter GDP, COVID-19 vaccination, rise in electricity prices, Page Industries, Jyothy Labs and more

India on the right side of gas cycle, but has to do more to avoid supply shocks

BUSINESS

India on the right side of gas cycle, but has to do more to avoid supply shocks

Domestic natural gas production grew for the fifth consecutive month, rising about 18 percent in July

IT companies' outlook brightens on rising demand for cloud services

BUSINESS

IT companies' outlook brightens on rising demand for cloud services

Global technology companies have reported robust financial performance and many of them have raised their annual revenue outlook, indicating a strong demand environment

Aurobindo Pharma’s Cronus rethink is positive, but it needs to do more

BUSINESS

Aurobindo Pharma’s Cronus rethink is positive, but it needs to do more

Aurobindo Pharma terminated an agreement to acquire a majority stake in Cronus Pharma after the proposal stoked capital allocation concerns

Moneycontrol Pro Panorama | Equity markets get a reality check

BUSINESS

Moneycontrol Pro Panorama | Equity markets get a reality check

In today’s edition of Moneycontrol Pro Panorama: US Fed taper talk, commodity prices, herd immunity tracker, HDFC Bank, SpiceJet, RoDTEP rates and more

Healthcare | Hospital stocks trump Big Pharma in growth and outlook

BUSINESS

Healthcare | Hospital stocks trump Big Pharma in growth and outlook

Three of the five large drug companies reported weak earnings. But large hospital chains did well and expect business to return to near normal levels

Moneycontrol Pro Panorama| Recovery gains traction, but valuations are stiff

BUSINESS

Moneycontrol Pro Panorama| Recovery gains traction, but valuations are stiff

In today’s edition of Moneycontrol Pro Panorama: Economy’s uneven progress, how Afghan economy fared under the US, new COVID wave looms, housing revival, Burger King India, Petronet LNG, spectre of lockdown in Israel and more

M&M gets a shot at utility vehicle market share repair

BUSINESS

M&M gets a shot at utility vehicle market share repair

The recently launched XUV700 is competitively priced and has the potential to gain market share in the mid-sized SUV segment

Capital Goods | Steady orders, enquiries drive positive outlook for companies

BUSINESS

Capital Goods | Steady orders, enquiries drive positive outlook for companies

While order inflows gathered pace at Siemens, bookings rose for the second consecutive quarter at Thermax

Interview | We will do better than industry returns in green energy, says Prashant Jain, CEO of JSW Energy

BUSINESS

Interview | We will do better than industry returns in green energy, says Prashant Jain, CEO of JSW Energy

JSW Energy aims to increase the share of renewable energy capacity to 70 per cent by FY25. The company is collaborating with an Australian firm to explore opportunities in green hydrogen production

Soda ash cycle turns for Tata Chemicals, but the wait for battery business plan is on

BUSINESS

Soda ash cycle turns for Tata Chemicals, but the wait for battery business plan is on

Soda ash volumes for Tata Chemicals grew for the second consecutive quarter and prices in the spot market are rising

Moneycontrol Pro Panorama | RBI gives priority to growth but inflationary pressures stoke concerns

BUSINESS

Moneycontrol Pro Panorama | RBI gives priority to growth but inflationary pressures stoke concerns

In today’s edition of Moneycontrol Pro Panorama: RBI Monetary Policy, reduction in global food prices, Herd Immunity Tracker, Nykaa IPO, Cipla, Godrej Consumer Products earnings and more

Aditya Puri’s induction adds heft to Solara Pharma's growth plans

BUSINESS

Aditya Puri’s induction adds heft to Solara Pharma's growth plans

The company whose revenue grew at an average annual pace of 16.6 percent in the three years to FY21 aims to accelerate the growth rate to 25 percent in FY21-25.

Cement companies sight swift demand recovery

BUSINESS

Cement companies sight swift demand recovery

Contrary to fears, rural demand has recovered well after the second wave. Housing and infrastructure projects are expected to drive demand too. However, a severe third wave can pose a risk.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347